Figure 4.
Kaplan-Meier curves of progression-free survival (A) and overall survival (B) of advanced hepatocellular carcinoma receiving combination treatment of pembrolizumab plus bevacizumab plus intrahepatic hepatocellular carcinoma-directed external beam moderately hypo-fractionated radiotherapy. CI, confidence interval.